GS
Gopal Subhash Bure
About Gopal Subhash Bure
Data last updated:
Gopal Subhash Bure is a Director at Magolita International Private Limited (since 2024) and Additional Director at Sumsu Pharmaceuticals Private Limited (Opc) (since 2019). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Magolita International Private Limited U46101MH2024PTC425350 | Director | 16 May 2024 | 2024 | Active | |
| Sumsu Pharmaceuticals Private Limited (Opc) U85195MH2014OPC258477 | Additional Director | 14 Jun 2019 | 2014 | Active |
Board colleagues of Gopal Subhash Bure
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bure Mahadeo Subhash | 06963850 | Magolita International Private Limited , Sumsu Pharmaceuticals Private Limited (Opc) | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gopal Subhash Bure
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopal Subhash Bure
Gopal Subhash Bure currently holds 2 directorships: Magolita International Private Limited (Director, since 16 May 2024); Sumsu Pharmaceuticals Private Limited (Opc) (Additional Director, since 14 Jun 2019).
Gopal Subhash Bure was first appointed on 14 Jun 2019 as Additional Director at Sumsu Pharmaceuticals Private Limited (Opc). The most recent appointment on record is 16 May 2024 at Magolita International Private Limited.
The current boards of Gopal Subhash Bure's companies include Bure Mahadeo Subhash (Magolita International Private Limited).